Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.79B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$576M |
| 3 |
Microsoft
MSFT
|
+$546M |
| 4 |
iShares MSCI EAFE ETF
EFA
|
+$436M |
| 5 |
JPMorgan Chase
JPM
|
+$324M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$2.48B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.73B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$765M |
| 4 |
Apple
AAPL
|
+$656M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$526M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 90.23% |
| 2 | Technology | 2.7% |
| 3 | Consumer Discretionary | 1.66% |
| 4 | Financials | 1.18% |
| 5 | Communication Services | 1.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3026
PUT
Innoviz Technologies
INVZ
$104M
| $6.76M | ﹤0.01% |
2,379,300
-245,900
| -9% | -$679K |
|
|
CERE
3027
CALL
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $6.76M | ﹤0.01% |
212,500
-45,100
| -18% | -$1.38M |
|
3028
Liberty Energy
LBRT
$3.1B
| $6.74M | ﹤0.01% |
504,437
+149,286
| +42% | +$1.93M |
|
3029
PUT
Vanguard Morningstar Small-Cap ETF
VB
$81.3B
| $6.74M | ﹤0.01% |
33,900
+21,200
| +167% | +$4.01M |
|
|
GTM
3030
CALL
ZoomInfo Technologies
GTM
$1.22B
| $6.73M | ﹤0.01% |
265,200
+30,000
| +13% | +$710K |
|
|
IMGN
3031
PUT
DELISTED
Immunogen Inc
IMGN
| $6.73M | ﹤0.01% |
356,700
-103,100
| -22% | -$1.22M |
|
3032
PUT
Gold Fields
GFI
$40.9B
| $6.73M | ﹤0.01% |
486,600
-57,500
| -11% | -$874K |
|
3033
CALL
Jack in the Box
JACK
$311M
| $6.73M | ﹤0.01% |
69,000
-40,300
| -37% | -$3.67M |
|
3034
PUT
Vir Biotechnology
VIR
$1.83B
| $6.73M | ﹤0.01% |
274,300
+166,000
| +153% | +$4.17M |
|
3035
PUT
iShares MSCI ACWI ETF
ACWI
$33.3B
| $6.73M | ﹤0.01% |
70,100
-3,400
| -5% | -$316K |
|
|
GAP
3036
The Gap Inc
GAP
$8.45B
| $6.72M | ﹤0.01% |
752,602
-799,196
| -52% | -$7.13M |
|
|
DEN
3037
PUT
DELISTED
Denbury Inc.
DEN
| $6.72M | ﹤0.01% |
77,900
-88,500
| -53% | -$8.02M |
|
3038
PUT
Rambus
RMBS
$9.3B
| $6.72M | ﹤0.01% |
104,700
+27,100
| +35% | +$1.49M |
|
3039
MDU Resources
MDU
$4.16B
| $6.71M | ﹤0.01% |
578,212
+537,083
| +1,306% | +$6.04M |
|
3040
Schwab US Large- Cap ETF
SCHX
$74.3B
| $6.7M | ﹤0.01% |
383,820
+271,569
| +242% | +$4.48M |
|
|
DQ
3041
Daqo New Energy
DQ
$926M
| $6.7M | ﹤0.01% |
168,675
-24,022
| -12% | -$1M |
|
3042
ProShares Ultra VIX Short-Term Futures ETF
UVXY
$276M
| $6.7M | ﹤0.01% |
14,486
+6,002
| +71% | +$4.82M |
|
3043
CALL
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$11.9B
| $6.69M | ﹤0.01% |
142,000
-55,800
| -28% | -$2.55M |
|
3044
PUT
Lumen
LUMN
$6.23B
| $6.69M | ﹤0.01% |
2,960,800
+265,500
| +10% | +$585K |
|
3045
iShares Gold Trust
IAU
$66.1B
| $6.69M | ﹤0.01% |
183,851
-83,982
| -31% | -$3.15M |
|
3046
Invesco
IVZ
$14.5B
| $6.69M | ﹤0.01% |
397,792
+116,461
| +41% | +$1.87M |
|
|
DICE
3047
PUT
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
| $6.69M | ﹤0.01% |
143,900
+114,300
| +386% | +$3.95M |
|
3048
United Airlines
UAL
$35.9B
| $6.68M | ﹤0.01% |
121,820
-1,144,127
| -90% | -$54M |
|
3049
Direxion Daily S&P Biotech Bear 3X ETF
LABD
$65.5M
| $6.67M | ﹤0.01% |
46,382
+38,538
| +491% | +$5.76M |
|
3050
LKQ Corp
LKQ
$6.46B
| $6.66M | ﹤0.01% |
114,363
-34,106
| -23% | -$1.9M |
|
Similar funds
Jeff Yass's Q2 2023 Portfolio in Review
As of Q2 2023, Jeff Yass held 13,811 positions worth $492B, up 4.6% from $470B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Jeff Yass's Q2 2023 filing shows 1,371 new, 4,862 increased, 5,559 reduced and 1,866 closed positions. Its largest new stake was State Street SPDR Portfolio Aggregate Bond ETF: 1,297,445 shares worth $32.9M. The largest sale was Invesco QQQ Trust, an estimated $2.48B.
By sector, the portfolio is most concentrated in Miscellaneous at 90% of assets, down from 90% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q2 2023 buy was State Street SPDR Portfolio Aggregate Bond ETF: 1,297,445 shares worth $32.9M.
- Jeff Yass added most to NVIDIA in Q2 2023, an estimated $1.79B increase.
- Jeff Yass's biggest Q2 2023 reduction was Invesco QQQ Trust, cutting an estimated $2.48B.
- Jeff Yass fully exited Vanguard Intermediate-Term Corporate Bond ETF in Q2 2023, selling an estimated $45.5M.
- Jeff Yass's ten largest holdings make up 30% of its $492B portfolio in Q2 2023.
- Jeff Yass opened 1,371 new positions and closed 1,866 in Q2 2023.
- Jeff Yass's portfolio value rose 4.6% quarter-over-quarter to $492B.
Based on Susquehanna International Group's 13F filing for Q2 2023, filed 11 Aug 2023.